Nicolas Burdin | Global Head of R&D
Clover Pharma

Dr. Nicolas Burdin serves as Global Head of R&D at Clover. Dr. Burdin has spent over 27 years in vaccine research and development (R&D) with increasing responsibility roles at Sanofi, contributing to the successful progression of multiple prophylactic and therapeutic projects against bacterial and viral targets. In his most recent positions of Scientific Attaché of Head of R&D and Global Head of Vaccine Portfolio Management at Sanofi, Nicolas and his teams have contributed to the development of new vaccines against infectious diseases and have enabled the strategic transformation of Sanofi Pasteur R&D and its New Vaccine pipeline. Those two decades of experience in the vaccine industry backed up by a robust academic research background- have allowed Nicolas to become an effectual leader for multidisciplinary R&D teams. He deploys his strategic and operational excellence assets to drive R&D programs internally and through collaborations, covering a broad portfolio of anti-infectious modalities (Mab, vaccines, and adjuvants), to successfully promote the translation of biological candidates into products.
Dr. Nicolas Burdin holds a Bachelor of Science degree and a Master of Immunology from the Lyon I University, a doctorate in the field of human B cell immunology (Schering Plough) and was a postdoctoral fellow at UCLA and at the La Jolla Institute for Allergy and Immunology in the fields of NK T cells and immunomodulation.